PATENT CLAIM ANALYSIS

Application Number: 15753541
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "134100"]

Abstract:
The present invention pertains to a fusion polypeptide for use in treating and/or preventing organ failure in a subject suffering from sepsis, said fusion polypeptide comprises at least (i) a first portion being a Fc portion of an immunoglobulin and (ii) a second portion comprising the extracellular portion of the human B7-H1 polypeptide or a variant thereof. Moreover, also encompassed by the invention is a polynucleotide encoding said fusion polypeptide for use in treating and/or preventing organ failure in a subject suffering from sepsis.

Claim (Index 10):
The method according to  claim 1 , wherein said fusion polypeptide is to be applied together with at least one further drug.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.7037
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11932327', '12547129', '11931653', '09794210', '11361057']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7187762881689282
- 35 USC 102 Novelty (BERT): 0.5140603992523672
- Combined Prediction Score: 0.6983046992772721
- Mean Citation Score: 267.395784
- Max Citation Score: 271.38733
- Similarity Product: 193.3012858204997

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test